Crane NXT Cuts Full-Year Sales Outlook Even as It Lifts Adjusted EPS Midpoint
CXT sits 73% above its 52-week low of $35.705 on elevated volume (2.5× avg).
Summary
Crane NXT posted Q3 sales of $497.1M, up 11.7% year-over-year, but only 1.1% of that was organic — acquisitions added $50M while the Detection and Traceability segment's organic sales fell 5.3%. GAAP net income dropped 24% to $38.4M and GAAP EPS fell to $0.66 from $0.87, though adjusted EPS held at $1.28 as intangible amortization and acquisition costs rose. The bigger issue is guidance: full-year sales growth was cut to ~14% from +15% to +17%, with DTT growth now high-teens versus low-20s previously, while the adjusted EPS range narrowed to $4.32-$4.42 and the midpoint moved up from $4.22-$4.42; the company also raised the midpoint of its 2026 adjusted EPS guidance. Cash generation was the bright spot at $112M from operations and 132% adjusted free cash flow conversion, supporting the year-end deleveraging target. This follows the August 11 8-K reaffirming the prior outlook, so the sales cut is a fresh negative against that baseline. Management discusses results on the November 5 call at 10:00 A.M. ET.
At the time of this announcement, CXT was trading at $61.62 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $35.71 to $65.56. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.